Literature DB >> 17101307

Simultaneous quantitation of the nucleotide analog adefovir, its phosphorylated anabolites and 2'-deoxyadenosine triphosphate by ion-pairing LC/MS/MS.

Jennifer E Vela1, Loren Y Olson, Alan Huang, Arnold Fridland, Adrian S Ray.   

Abstract

The nucleotide analog adefovir is an important therapy for hepatitis B viral infection. The study of nucleoside/tide pharmacology has been hampered by difficulties encountered when trying to develop LC/MS/MS methods for these polar analytes. In an attempt to identify a more convenient, selective and sensitive alternative to the analysis of the metabolism of radiolabeled parent nucleotide traditionally used for in vitro cell culture studies, an LC/MS/MS method was developed for the quantitative detection of adefovir and its phosphorylated metabolites in cellular samples. Ion-pairing reversed phase LC using tetrabutylammonium (TBA) and ammonium phosphate had the best compromise between chromatographic separation and positive mode MS/MS detection. Using microbore reverse phase columns and a low flow acetonitrile gradient it was possible to quantitate adefovir, its metabolites and 2'-deoxyadenosine triphosphate. A cross-validation showed comparable levels of adefovir and its metabolites were determined using either LC/MS/MS or radioactivity detection. However, initial methods were conducted at high pH and utilized an acetonitrile step gradient causing unacceptable column life and unpredictable equilibration. Further method optimization lowered the concentration of TBA and phosphate, decreased pH and applied a linear gradient of acetonitrile. This work resulted in a method that was found to have sensitivity, accuracy and precision sufficient to be a useful tool in the study of the intracellular pharmacology of adefovir in vitro and may be more broadly applicable.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17101307     DOI: 10.1016/j.jchromb.2006.10.063

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  13 in total

1.  Fluorescence and electrochemical recognition of nucleosides and DNA by a novel luminescent bioprobe Eu(III)-TNB.

Authors:  Hassan A Azab; E M Mogahed; F K Awad; R M Abd El Aal; Rasha M Kamel
Journal:  J Fluoresc       Date:  2012-05       Impact factor: 2.217

2.  A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1.

Authors:  Nicholas T Hertz; Amandine Berthet; Martin L Sos; Kurt S Thorn; Al L Burlingame; Ken Nakamura; Kevan M Shokat
Journal:  Cell       Date:  2013-08-15       Impact factor: 41.582

Review 3.  Direct and indirect quantification of phosphate metabolites of nucleoside analogs in biological samples.

Authors:  Nagsen Gautam; Jawaher Abdullah Alamoudi; Sushil Kumar; Yazen Alnouti
Journal:  J Pharm Biomed Anal       Date:  2019-10-03       Impact factor: 3.935

4.  Simultaneous quantification of intracellular natural and antiretroviral nucleosides and nucleotides by liquid chromatography-tandem mass spectrometry.

Authors:  Emilie Fromentin; Christina Gavegnano; Aleksandr Obikhod; Raymond F Schinazi
Journal:  Anal Chem       Date:  2010-03-01       Impact factor: 6.986

5.  Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects.

Authors:  Koen K A Van Rompay; Lucie Durand-Gasselin; Laurie L Brignolo; Adrian S Ray; Kristina Abel; Tomas Cihlar; Abigail Spinner; Christopher Jerome; Joseph Moore; Brian P Kearney; Marta L Marthas; Hans Reiser; Norbert Bischofberger
Journal:  Antimicrob Agents Chemother       Date:  2008-06-23       Impact factor: 5.191

6.  Baseline CD4+ T-cell counts predict HBV viral kinetics to adefovir treatment in lamivudine-resistant HBV-infected patients with or without HIV infection.

Authors:  K J Cortez; M A Proschan; L Barrett; D G Brust; Barry Weatherley; E Formentini; R T Davey; H Masur; M A Polis; A U Neumann And; S Kottilil
Journal:  HIV Clin Trials       Date:  2013 Jul-Aug

7.  Nucleotide analogue prodrug tenofovir disoproxil enhances lymphoid cell loading following oral administration in monkeys.

Authors:  Lucie Durand-Gasselin; Koen K A Van Rompay; Jennifer E Vela; Ilana N Henne; William A Lee; Gerry R Rhodes; Adrian S Ray
Journal:  Mol Pharm       Date:  2009 Jul-Aug       Impact factor: 4.939

8.  Intracellular metabolism of the nucleotide prodrug GS-9131, a potent anti-human immunodeficiency virus agent.

Authors:  Adrian S Ray; Jennifer E Vela; Constantine G Boojamra; Lijun Zhang; Hon Hui; Christian Callebaut; Kirsten Stray; Kuei-Ying Lin; Ying Gao; Richard L Mackman; Tomas Cihlar
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

9.  Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131.

Authors:  Tomas Cihlar; Adrian S Ray; Constantine G Boojamra; Lijun Zhang; Hon Hui; Genevieve Laflamme; Jennifer E Vela; Deborah Grant; James Chen; Florence Myrick; Kirsten L White; Ying Gao; Kuei-Ying Lin; Janet L Douglas; Neil T Parkin; Anne Carey; Rowchanak Pakdaman; Richard L Mackman
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

10.  Liquid chromatography-tandem mass spectrometry method for the estimation of adefovir in human plasma: Application to a pharmacokinetic study.

Authors:  Dipanjan Goswami; Sanjay Gurule; Arabinda Saha; Poonam Vats; Arshad Khuroo; Tausif Monif
Journal:  J Pharm Anal       Date:  2014-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.